NEXGEL to Participate in the 6th Annual CEO Networking Event Hosted by Semco Capital on June 2nd

NEXGEL, Inc. (NASDAQ: NXGL), a prominent provider of innovative healthcare and over-the-counter products featuring ultra-gentle, high-water-content hydrogels, has announced its participation in the 6th Annual CEO Networking Event hosted by Semco Capital. The event is slated for June 2, 2025, in Chicago and will run from 1 to 9 p.m. CT. Adam Levy, the CEO of NEXGEL, will take part in a fireside chat moderated by Scott Weis of Semco Capital, discussing the company's vision and growth trajectory.

This annual event serves as a gathering point for elite microcap companies with distinctive business models and capable management teams. It provides a platform for networking among investors and executives, aiming to enhance value and growth opportunities for participating companies. Investors interested in attending can reach out to Scott Weis at Semco Capital via email for further details.

NEXGEL, headquartered in Langhorne, Pennsylvania, has over 20 years of expertise in developing electron-beam, cross-linked hydrogels used in a variety of applications, from medical to beauty products. Their reputable brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm®, and Silly George®. NEXGEL also holds strategic manufacturing partnerships with established consumer healthcare firms, reinforcing its position in the market.

With its strong commitment to innovation and quality, NEXGEL continues to be a pivotal player in the healthcare space, and its participation in high-profile events like the Annual CEO Networking Event further emphasizes its growth potential and industry influence. For investors, this creates an opportunity to engage directly with company leadership and gain insights into future developments at NEXGEL.

NEXGEL, Inc. (NASDAQ: NXGL) presents a compelling opportunity for investors as it prepares to participate in the 6th Annual CEO Networking Event hosted by Semco Capital on June 2, 2025. This event assembles prominent microcap companies known for their innovative business models and growth potential. Adam Levy, NEXGEL’s CEO, will engage in discussions that may enhance visibility and attractiveness to a broader investor community, highlighting the company’s strategic intent to drive growth.

NEXGEL specializes in ultra-gentle, high-water-content hydrogels, which have applications across healthcare and consumer markets, including their well-regarded brands like SilverSeal® and Hexagels®. The company has demonstrated a commitment to innovation, as evidenced by its two decades of experience in developing electron-beam, cross-linked hydrogels. This differentiation in product offerings not only positions NEXGEL as a leader in its sector but also underscores its potential for future profitability.

Given the focus on microcap companies at the Semco Capital event, it’s essential to monitor NEXGEL's performance and market perception following the networking opportunity. Companies participating in such events often see increased attention, which can drive stock price movements. Investors should consider engaging with the company’s developments during and after the event, particularly in response to feedback from institutional investors who might attend and gain insights into NEXGEL's business operations and growth strategy.

Furthermore, with strategic partnerships established for contract manufacturing, NEXGEL is well-placed to expand its market reach, enhancing revenue potentials. Therefore, prospective and current investors should maintain a close watch on upcoming developments and market trends surrounding NEXGEL, as the exposure from the CEO Networking Event may catalyze further interest in the company's growth narrative.